The reason the FDA gave MACK Fast Track approval is because there are no current therapies for pancreatic cancer -- the drug meets an unmet medical need.

Alnylam Pharmaceuticals announced it has completed enrollment in its Phase 2 clinical trial with revusiran.Merrimack Pharmaceuticals announced the U.S. FDA has granted orphan drug designation for the treatment of pancreatic cancer.

Not all earnings surprises are created equal.

The average small cap score this week is 48.46, above the four week moving average score of 46.12. The average small cap is trading -25.83% below its 52 week high, -3.53% below its 200 dma, and has 8.93 days to cover held short.

Utilities remains the top scoring sector. Industrial goods, consumer goods, and basic materials score in line with the average universe score. Financials, healthcare, services, and technology score below average.

For this report, utilities are the top scoring small cap sector and the best small cap industry is trucking.